3月27日(譌･) 9:00�ｽ�11:00 K会場 繝代す繝輔ぅ繧ｳ讓ｪ豬懊莨夊ｭｰ繧ｻ繝ｳ繧ｿ繝ｼ縲3F縲313+314 GS02 縺吶∋縺ｦ縺ｮ驕薙�ｯ謔｣閠�縺ｫ騾壹★縲�ｽ朮OL繧帝ｫ倥￥邯ｭ謖√☆繧句現逋ゅｒ逶ｮ謖�縺励※�ｽ� All Roads Lead to Patients窶尿dvancing Medical Treatment that Maintain High Quality of Life窶� 繧ｪ繝ｼ繧ｬ繝翫う繧ｶ繝ｼ�ｼ壼ｲ｡譛ｬ 蠖ｩ鬥吶∝ｮｮ譛ｬ 蟇帛ｭ� GS02-1 Abl蜿翫�ｳSrc kinases縺ｫ繧医ｋ陦豸ｲ閼ｳ髢｢髢P-glycoprotein縺ｮ邏ｰ閭槫��繝医Λ繝輔ぅ繝�繧ｭ繝ｳ繧ｰ蛻ｶ蠕｡讖滓ｧ九�ｮ隗｣譏� The involvement of Abl and Src kinases in the intracellular trafficking of P-gp at the blood-brain barrier. シンポジスト ： 笳区弌 陬募､ｪ譛励∝��逕ｰ 蠎ｷ髮�縲∫ｫ句ｷ� 豁｣諞ｲ縲∝､ｧ讒ｻ 邏皮塙縲∝ｯｺ蟠� 蜩ｲ荵� GS02-2 SBDD縺ｫ蝓ｺ縺･縺�縺溷､壼王謗貞�ｺ繝医Λ繝ｳ繧ｹ繝昴�ｼ繧ｿ繝ｼ髦ｻ螳ｳ蜑､縺ｮ髢狗匱 Development of multidrug efflux transporter inhibitors by Structure Based Drug Design シンポジスト ： 笳倶ｺ穂ｸ� 髮�螟ｪ縲∝ｱｱ蟠� 閨門昇縲∵ｫｻ莠� 蝠謎ｻ九∵ｨ句哨 髮�莉九∝ｱｱ蜿｣ 譏惹ｺｺ縲∝刈阯､ 菫ｮ髮� GS02-3 陦豬∽ｸｭ縺ｧ讖溯�ｽ縺吶ｋ驟ｵ邏蟆∝�･繝昴Μ繧､繧ｪ繝ｳ繧ｳ繝ｳ繝励Ξ繝�繧ｯ繧ｹ蝙九�吶す繧ｯ繝ｫ縺ｮ髢狗匱 Development of enzyme-loaded polyion complex vesicles working in blood circulation シンポジスト ： 笳区忰蜷� 螟ｧ霈昴∝ｮ画･ｽ 豕ｰ蟄昴∫援蟯｡ 荳蜑� GS02-4 陦貂�繧｢繝ｫ繝悶Α繝ｳ縺ｫ繧医▲縺ｦ陦荳ｭ貊樒蕗諤ｧ縺悟髄荳翫☆繧区眠隕城⊆莨晏ｭ舌く繝｣繝ｪ繧｢縺ｮ髢狗匱 Development of biocompatible gene carrier utilizing serum albumin シンポジスト ： 笳倶ｸｭ譚� 髮�螟ｪ縲∝ｱｱ譛ｬ 遶懷ｺ�縲∝ｲｸ譚� 鬘募ｺ�縲∵｣ｮ 蛛･縲∫援螻ｱ 菴ｳ讓ｹ GS02-5 PEG 蛹冶痩驟ｸ菫ｮ鬟ｾ繝�繝ｳ繝峨Μ繝槭�ｼ/ﾎｱ-繧ｷ繧ｯ繝ｭ繝�繧ｭ繧ｹ繝医Μ繝ｳ邨仙粋菴難ｼ�G4�ｼ峨↓繧医ｋ縺後ｓ邏ｰ閭樣∈謚樒噪譬ｸ驟ｸ蛹ｻ阮ｬ蜈ｨ霄ｫ繝�繝ｪ繝舌Μ繝ｼ繧貞茜逕ｨ縺励◆縺後ｓ豐ｻ逋よ姶逡･ Cancer treatment strategy utilizing tumor cell-selective and systemic nucleic acid drugs delivery by folate-PEG-appended dendrimer (G4) conjugate with ﾎｱ-cyclodextrin シンポジスト ： 笳句､ｧ螻ｱ 豁ｩ蜍吶∽ｹ咎� 蜍�蟶後∵擲 螟ｧ蠢励∵悽螻ｱ 謨ｬ荳縲∵怏鬥ｬ 闍ｱ菫� GS02-6 繝舌う繧ｪ繧､繝ｳ繝輔か繝槭ユ繧｣繧ｯ繧ｹ繧貞ｿ懃畑縺励◆螳滄ｨ薙ョ繝ｼ繧ｿ縺ｮ豢ｻ逕ｨ縺ｨ蜑ｵ阮ｬ縺ｮ蜉ｹ邇�蛹� Effective utilization of experimental data and efficiency of drug development by an application of bioinformatics シンポジスト ： 笳区ｲｳ蜷� 鬧ｿ縲∬淹豎� 諷ｧ縲∝刈阯､ 遶懷昇 検索ページに戻る
